期刊
INTERNATIONAL JOURNAL OF IMMUNOGENETICS
卷 49, 期 1, 页码 39-45出版社
WILEY
DOI: 10.1111/iji.12565
关键词
antibodies; ELISpot; HLA; interferon-gamma; organ transplantation; rejection
资金
- Ministry of Health of the Czech Republic [NT/14022-3]
- MH CZ - DRO (Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]
The ELISpot assay is a sensitive technique used to assess immune responses, and despite being difficult to standardize, it can provide valuable information for organ transplant recipients.
The ELISpot assay is a sensitive technique applied to assess cytokine-producing memory/effector T cells and human leukocyte antigens (HLA)-specific IgG-producing B cells. Besides the fact that the method is laborious and is difficult to standardise between laboratories, it may provide valuable information on the immune response of recipients before and after organ transplantation. In this article, we briefly review the recent literature and discuss the clinical significance of the ELISpot assay in predicting the risk and incidence of allograft rejection and survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据